News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Matt Yurgelun: I’ll be walking to raise money for the Dana Farber Lynch Syndrome Center
Photo taken from Matthew Yurgelun/dana-farber.org
Sep 2, 2024, 07:14

Matt Yurgelun: I’ll be walking to raise money for the Dana Farber Lynch Syndrome Center

Matt Yurgelun,

On October 6, I’ll be walking to raise money for the Dana Farber Lynch Syndrome Center. 100% of funds raised will support Lynch Syndrome education, research, and patient care. 

Click here to donate.”

Support the Boston Marathon Jimmy Fund Walk

Source: Matt Yurgelun/X

cancer Dana Farber Lynch Syndrome Center Harvard Medical School Lynch Syndrome Matt Yurgelun OncoDaily Oncology
Special Coverage
Blog
Sep 2, 2024, 07:14
Matt Yurgelun: I’ll be walking to raise money for the Dana Farber Lynch Syndrome Center
Insight
Sep 2, 2024, 07:05
Samuel Bakhoum: The role of mitochondria and free radicals in promoting the collapse of cancer micronuclei
Blog
Sep 2, 2024, 07:02
Colton Ladbury received 2024 ASTRO Annual Meeting Abstract Recognition Award
Blog
Sep 2, 2024, 07:00
The connection between a new class of weight loss drugs and cancer risk reduction - MSKCC
Societies
Sep 2, 2024, 06:54
The beginning of Gold September - SIOP Europe
Societies
Sep 2, 2024, 06:48
American Society of Clinical Oncology (ASCO)'s Medical Education Community of Practice TOWN HALL
Insight
Sep 2, 2024, 04:06
23rd Annual Hispanic Women of Distinction Charity Luncheon
Insight
Sep 2, 2024, 03:56
Francisco J. Esteva: The critical role of regular screenings in improving breast cancer outcomes
Insight
Sep 2, 2024, 03:50
National Cancer Society Malaysia is one of the proud recipients of the Home Away From Home grant
Insight
Sep 2, 2024, 03:41
FDA Grants Zongertinib Breakthrough Therapy Designation in HER2-Mutant NSCLC
Insight
Sep 2, 2024, 03:14
Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials
Insight
Sep 1, 2024, 23:16
Susanna F. Greer: BRCA2: The Master Chef of DNA